Stay updated with breaking news from Rob Howard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has approved a new drug for patients in the early-stages of Alzheimer's disease but growing concerns over its safety and real-world efficacy have led to division amongst researchers, with some suggesting it should not be authorized for wide use.
Former Blue Peter presenter Lindsey Russell is the new host of Early Breakfast at Heart, whilst Capital's Rob Howard gets the weekend editions.
This is the 100% electric Kindred 3100, it's a new electric pickup truck slated to begin low-volume production in 2024, and pre-order slots are now
Lecanemab appeared to slow progression of the disease in a phase three Alzheimer's drug trial. But how effective is the drug really?